<SEC-DOCUMENT>0001140361-26-011784.txt : 20260327
<SEC-HEADER>0001140361-26-011784.hdr.sgml : 20260327
<ACCEPTANCE-DATETIME>20260327170025
ACCESSION NUMBER:		0001140361-26-011784
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260319
FILED AS OF DATE:		20260327
DATE AS OF CHANGE:		20260327

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Larsen Charles
		CENTRAL INDEX KEY:			0001857458
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40492
		FILM NUMBER:		26808329

	MAIL ADDRESS:	
		STREET 1:		28 SANDPIPER ROAD
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33609

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FEMASYS INC
		CENTRAL INDEX KEY:			0001339005
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				113713499
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3950 JOHNS CREEK COURT
		STREET 2:		SUITE 100
		CITY:			SUWANEE
		STATE:			GA
		ZIP:			30024
		BUSINESS PHONE:		770-500-3910

	MAIL ADDRESS:	
		STREET 1:		3950 JOHNS CREEK COURT
		STREET 2:		SUITE 100
		CITY:			SUWANEE
		STATE:			GA
		ZIP:			30024
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0609</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2026-03-19</periodOfReport>

    <issuer>
        <issuerCik>0001339005</issuerCik>
        <issuerName>FEMASYS INC</issuerName>
        <issuerTradingSymbol>FEMY</issuerTradingSymbol>
        <issuerForeignTradingSymbol></issuerForeignTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001857458</rptOwnerCik>
            <rptOwnerName>Larsen Charles</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
            <rptOwnerStreet1>C/O FEMASYS INC.</rptOwnerStreet1>
            <rptOwnerStreet2>3950 JOHNS CREEK COURT, SUITE 100</rptOwnerStreet2>
            <rptOwnerCity>SUWANEE</rptOwnerCity>
            <rptOwnerState>GA</rptOwnerState>
            <rptOwnerZipCode>30024</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>false</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Series D-1 Warrants</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.58</value>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2026-03-19</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>34122</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2026-03-19</value>
            </exerciseDate>
            <expirationDate>
                <value>2036-03-19</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common stock, par value $0.001 per share</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>34122</value>
                    <footnoteId id="F2"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>34122</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Holder may, at its option, exercise the Series D-1 Warrants, subject to the terms and conditions thereof, at an initial exercise price of $0.58 per share of Common Stock. The exercise price is subject to adjustment in accordance with the terms of the Series D-1 Warrants and will be subject to standard adjustments in the event of any stock split, stock dividend, stock combination, recapitalization or other similar transactions.</footnote>
        <footnote id="F2">The Holder's ability to exercise the subject Warrant for shares of Common Stock is subject to certain limitations, in accordance with rules of the Nasdaq Capital Market.</footnote>
        <footnote id="F3">The reported securities were issued to the reporting person in a private placement as consideration in connection with that certain Omnibus Amendment and Consent Agreement, dated as of March 19, 2026 by and among the Company, the reporting person and the other parties thereto.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Kathy Lee-Sepsick, Attorney-in-fact</signatureName>
        <signatureDate>2026-03-27</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
